Orchid Pharma Ltd has received the Establishment Inspection Report (EIR) from USFDA based on the successful inspection of the formulation manufacturing facility located at Plot Nos. B5 (Pt) & B6 (Pt), SIPCOT Industrial Park, Irungattukottai, Sriperumbudur, Kancheepuram District, 602105, Tamil Nadu, India.
The facility was inspected by USFDA in December 2016.
Shares of ORCHID PHARMA LTD. was last trading in BSE at Rs.36.55 as compared to the previous close of Rs. 34.7. The total number of shares traded during the day was 1760084 in over 7649 trades.
The stock hit an intraday high of Rs. 39.7 and intraday low of 34.25. The net turnover during the day was Rs. 66503805.